NANEMIAR Project The NANEMIAR consortium held its 4th consortium meeting in Bilbao, taking advantage of the SEHH congress to bring project members together and review the progress of the project. The meeting focused on discussing the data generated to date, reviewing the project's current status, and evaluating progress toward its scientific object...
News & Events
We are delighted to share that OCAI Lab has been selected for Best Presentation in Erythropathology at the meeting of the Spanish Society of Hematology and Hemotherapy (SEHH), held in Bilbao from 22 to 24 October 2026. This recognition is a great motivation to continue advancing research and innovation, while raising awareness of our project, NANEM...
September 25, 2026 | Murcia, Spain The NANEMIAR team, part of the Murcian Institute of Biosanitary Research (IMIB), participated in the European Researchers’ Night 2026, one of Europe’s largest science outreach events, promoted by the European Commission within the framework of the Marie Skłodowska-Curie Actions of the Horizon Europe programme. On ...
In this next interview Dr. Jurgen Dieker, CSO at Mercurna (Netherlands) shares with us his personal experience working in a biotech start-up and reveals what motivates to co-found Mercurna. Dr. Jurgen Dieker, CSO at Mercurna who is a beneficiary of the NANEMIAR Project, explains to us what his role is within NANEMIAR. Hi, Jurgen! Thank you very muc...
NANEMIAR are participating in the European Hematology Association Congress (EHA 2026), one of the most important international scientific meetings in the field of hematology. Dr. Perez-Oliva was invited as a speaker in today's session, "Inflammasome in Congenital Anemias", where she delivered a presentation entitled "Inflammasome and Its Implicatio...